ASMB 2023: Tissue, Matrix, and Pathobiology

ASMB 2023：组织、基质和病理生物学

• 批准号: 10752769
• 负责人: AMBRA POZZI
• 金额: $ 5.5万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-07-06 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10752769
• 关键词: Age; Aging; American; Area; Award; Basic Science; Biochemistry; Biology; Biomedical Engineering; Bone Development; Career Choice; Cellular biology; Cities; Clinical Research; Collaborations; Communication; Communities; Connective Tissue; Data; Diet; Disease; Ensure; Equipment; Extracellular Matrix; Faculty; Feedback; Fostering; Functional disorder; Funding; Funding Mechanisms; Genetic Diseases; Goals; Health; Homeostasis; Human; Image; Inflammatory Response; Injury to Kidney; Investigation; Joints; Knowledge; Leadership; Mediating; Mentors; Mission; Molecular; Morphogenesis; Natural regeneration; Organ; Organoids; Pathology; Persons; Postdoctoral Fellow; Process; Proteins; Research; Research Personnel; Resources; Role; Science; Scientist; Seminal; Signal Transduction; Societies; Sodium Chloride; Technology; Therapeutic Intervention; Thinking; Tissues; Training; Translating; Translational Research; Travel; Underrepresented Minority; Underrepresented Populations; United States National Institutes of Health; Utah; Visual; Woman; Work; cardiovascular injury; career; career development; cartilage development; cost; design; diversity and inclusion; experience; graduate student; host neoplasm interaction; human disease; improved; interest; knowledge translation; meetings; member; minority trainee; multidisciplinary; musculoskeletal injury; next generation; novel therapeutic intervention; posters; pre-doctoral; programs; receptor; repaired; scaffold; sex; success; symposium; tool; tumor

We request partial support for the 11th Biennial American Society for Matrix Biology (ASMB) conference entitled “Tissue, Matrix, and Pathobiology”. This in-person meeting will take place October 22-25, 2023 in Salt Lake City, Utah. This is a new multidisciplinary and collaborative joint meeting among three major societies: ASMB, the American Society for Investigative Pathology, and The Histochemical Society. It will feature cutting edge basic, clinical, and translational research related to a variety of topics that reflect normal biology of cells/tissues, and the molecular and cellular alterations that drive disease processes. This meeting will have a common keynote speaker and 3 common Plenary Sessions of interest for all members of the three societies. Importantly, the meeting will have an ASMB tailored program focused on promoting the field of matrix biology in order to disseminate knowledge about the extracellular matrix (ECM) and to translate this knowledge to improve human health and aging and to better treat human disease. The Aims of this R13 application are: Aim 1: To disseminate and integrate new knowledge about ECM and its receptors in health, disease, aging, and regeneration. The ASMB 2023 program reflects the diverse interests of the matrix biology scientific community. It expands and evolves areas of interest for matrix biology, such as the tumor/stroma microenvironment; aging- related diseases involving ECM changes; the role of sex and diet in ECM changes and disease; cardiovascular and musculoskeletal injury and regeneration; bone and cartilage development, disease, and regeneration; tools to study ECM signaling; and technologies for therapeutic intervention and for imaging ECM in health and disease. Aim 2: To contribute to training the next generation of scientists, and to foster the careers of junior investigators in the area of ECM. ASMB 2023 has invited junior faculty to speak in both Plenary and Concurrent Sessions. Each Concurrent Session will have a co-chair chosen from junior faculty and/or senior postdocs and talks selected from submitted abstracts, giving trainees and junior faculty opportunities to present their work. ASMB 2023 will also offer postdocs the opportunity to organize and chair special interest sessions. Career mentoring breakfasts and interactive poster sessions will also support career development. ASMB’s Junior Investigator Award, Founders’ Award, and Iozzo Trainee Awards will highlight junior scientists. Travel Awards will be provided to competitive trainees. Aim 3: To enhance diversity and inclusion by promoting the career of women and under- represented minorities (URM). ASMB 2023 will showcase the work of 5 women (of 9 speakers) in 3 Plenary Sessions; 4 women and 1 URM (of 9 speakers) in 3 Guest Symposia; 8 women and 2 URM (of 16 speakers) in 16 Concurrent Sessions. Of a total of 39 invited speakers, 17 are women (43%). A mentoring breakfast devoted to career development issues particular to women will also be held. In the selection of speakers, we have focused on including those from diverse backgrounds. In addition, ASMB has reserved travel awards for URM trainees. Overall, this conference will be, as it has always been, the seminal conference in the field of ECM research.

我们请求对第 11 届两年一度的美国基质生物学学会 (ASMB) 会议提供部分支持，该会议题为 “组织、基质和病理学”会议将于 2023 年 10 月 22 日至 25 日在盐湖城举行。 这是犹他州三个主要学会之间新的多学科协作联合会议：ASMB、 美国研究病理学学会和组织化学学会将以尖端基础、 与反映细胞/组织正常生物学的各种主题相关的临床和转化研究，以及 这次会议将有一个共同的主题演讲。 演讲者和三个协会所有成员都感兴趣的 3 场共同全体会议。 会议将有一个 ASMB 量身定制的计划，重点是促进基质生物学领域的发展，以便 传播有关细胞外基质（ECM）的知识并将这些知识转化为改善人类 R13 应用程序的目标是： 目标 1：传播和整合有关 ECM 及其受体在健康、疾病、衰老和健康方面的新知识 ASMB 2023 计划反映了基质生物学科学界的不同兴趣。 它扩展并发展了基质生物学感兴趣的领域，例如肿瘤/基质微环境； 涉及 ECM 变化的相关疾病；性别和饮食在 ECM 变化和心血管疾病中的作用； 肌肉骨骼损伤和再生；骨骼和软骨发育、疾病和再生工具； 研究 ECM 信号传导；以及健康和疾病中的治疗干预和 ECM 成像技术。 目标 2：为培养下一代科学家做出贡献，并促进初级研究人员的职业生涯 ASMB 2023 邀请了初级教师在全体会议和同期会议上发言。 每个同期会议将有一位从初级教师和/或高级博士后中选出的联合主席和演讲 从提交的摘要中进行选择，为学员和初级教师提供展示其作品的机会。 2023 年还将为博士后提供组织和主持特殊兴趣会议的机会。 早餐和互动海报会议也将支持 ASMB 的初级研究员的职业发展。 奖、创始人奖和 Iozzo 实习生奖将颁发给青年科学家旅行奖。 目标 3：通过促进女性和弱势群体的职业发展来增强多样性和包容性。 代表少数群体 (URM) 将在第三次全体会议上展示 5 名女性（9 名发言者）的工作。 会议；3 场客座研讨会中有 4 名女性和 1 位 URM（共 9 名发言者）；8 名女性和 2 位 URM（共 16 名发言者） 16 场同期会议，共有 39 名受邀演讲者，其中 17 名是女性（43%）。 在选择演讲者时，我们也重点讨论了女性的职业发展问题。 此外，ASMB 还为 URM 学员保留了旅行奖励。 总的来说，本次会议将一如既往地成为 ECM 研究领域的开创性会议。